EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Retrospective Analysis of Graft Loss Risk in Patients with BK Polyomavirus Associated Nephropathy in Relation to Rejection Status in a Multicentre Cohort with Regular Surveillance of BK Polyomavirus and Donor-Specific Antibody

Maggie Kam-Man Ma, Jasper Fuk-Woo Chan, Tsz-Ling Ho, Darwin Chi-Kwan Lam, William Lee, Ho-Kwan Sin, Cheuk-Chun Szeto, Chi-Kwan Wong, Sydney Chi-Wai Tang

American Journal of Nephrology · 14.11.2025 · 1-10

DOI: 10.1159/000549450 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift American Journal of Nephrology, online erschienen am 14.11.2025. Verfasst von Maggie Kam-Man Ma und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, Hong Kong, China, makmm@ha.org.hk. Hauptthemen laut MEDLINE: BK Virus, Kidney Transplantation, Polyomavirus Infections, Graft Rejection. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

BK polyomavirus (BKPyV) in kidney transplant associated with adverse graft outcome. The aim of this study was to examine graft loss risk of BKPyV associated nephropathy (BKPyVAN) and BKPyV-DNAemia in relation with de novo donor-specific antibody (DSA) and rejection status.

Methods

Two hundred and forty patients from a multicentre cohort who had regular BKPyV and donor-DSA surveillance were retrospectively reviewed and stratified according to the presence of BKPyV-DNAemia and rejection.

Results

BKPyV-DNAemia did not associate with de novo DSA development (hazard ratio [HR] 1.15, 95% confidence interval [CI] 0.50–2.67, p = 0.74) but de novo DSA was more commonly observed in patients who developed rejection (BKV+/rejection– 4.3% (n = 2) vs. BKV+/rejection+ 57.1% (n = 4), p < 0.001). BKPyV-DNAemia (adjusted HR 4.02, 95% CI: 1.30–12.43, p = 0.016) and de novo DSA (adjusted HR 6.76, 95% CI: 2.51–18.24, p < 0.001) were independent factors associated with antibody-mediated rejection. Patients with BKPyV-DNAemia who were further complicated with rejection had approximately 6-fold risk of graft loss (adjusted HR 6.24, 95% CI: 2.04–19.09, p = 0.001), whereas patient with BKPyV-DNAemia alone did not experience significant increase graft loss risk (adjusted HR 1.76, 95% CI: 0.64–4.81, p = 0.27).

Conclusions

Our study suggested that DSA monitoring would be warranted during immunosuppressant reduction for BKPyV-DNAemia and less aggressive reduction of immunosuppressant when DSA emerges might be a reasonable strategy to avoid overzealous reduction of immunosuppressant that could precipitate allograft rejection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BK VirusKidney TransplantationPolyomavirus InfectionsGraft RejectionTumor Virus InfectionsKidney DiseasesHumansFemaleMaleMiddle AgedRetrospective StudiesAdultDNA, ViralRisk FactorsIsoantibodies

Stichwörter der Autor:innen

BK polyomavirusDonor-specific antibodyGraft survivalKidney transplantationRejection

Substanzen

DNA, ViralIsoantibodies

Autor:innen und Institutionen

  • Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, Hong Kong, China, makmm@ha.org.hk.
  • Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong, China.
  • Department of Medicine, Tseung Kwan O Hospital, Hong Kong, Hong Kong, China.
  • Department of Medicine and Geriatrics, United Christian Hospital, Hong Kong, Hong Kong, China.
  • Department of Medicine and Geriatrics, Princess Margaret Hospital, Hong Kong, Hong Kong, China.
  • Department of Medicine and Geriatrics, Kwong Wah Hospital, Hong Kong, Hong Kong, China.

Zitieren

APA

Ma, M. K., Chan, J. F., Ho, T. L., Lam, D. C., Lee, W., Sin, H. K., Szeto, C. C., Wong, C. K., & Tang, S. C. (2025). Retrospective Analysis of Graft Loss Risk in Patients with BK Polyomavirus Associated Nephropathy in Relation to Rejection Status in a Multicentre Cohort with Regular Surveillance of BK Polyomavirus and Donor-Specific Antibody. American Journal of Nephrology, 1-10. https://doi.org/10.1159/000549450

Vancouver

Ma MK, Chan JF, Ho TL, Lam DC, Lee W, Sin HK, et al. Retrospective Analysis of Graft Loss Risk in Patients with BK Polyomavirus Associated Nephropathy in Relation to Rejection Status in a Multicentre Cohort with Regular Surveillance of BK Polyomavirus and Donor-Specific Antibody. American Journal of Nephrology. 2025:1-10. doi:10.1159/000549450

BibTeX
@article{Ma2025,
  author = {Ma, Maggie Kam-Man and Chan, Jasper Fuk-Woo and Ho, Tsz-Ling and Lam, Darwin Chi-Kwan and Lee, William and Sin, Ho-Kwan and Szeto, Cheuk-Chun and Wong, Chi-Kwan and Tang, Sydney Chi-Wai},
  title = {Retrospective Analysis of Graft Loss Risk in Patients with BK Polyomavirus Associated Nephropathy in Relation to Rejection Status in a Multicentre Cohort with Regular Surveillance of BK Polyomavirus and Donor-Specific Antibody},
  journal = {American Journal of Nephrology},
  year = {2025},
  pages = {1--10},
  doi = {10.1159/000549450}
}
Kostenlos starten →